Yang-gon Jin, chairman of HLB, “Riboceranib clinical trial is successful…definitely new drug development”
![[단독] HLB suspects false disclosure of FDA clinical results… Gtree B&T’s late investigation](https://image.chosun.com/sitedata/image/202102/16/2021021600613_0.jpg "[단독] HLB suspects false disclosure of FDA clinical results… Gtree B&T’s late investigation")
